Table of Contents EMEA (Europe, Middle East and Africa) Therapeutic Vaccines Market Report 2018 1 Therapeutic Vaccines Overview 1.1 Product Overview and Scope of Therapeutic Vaccines 1.2 Classification of Therapeutic Vaccines 1.2.1 EMEA Therapeutic Vaccines Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA Therapeutic Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Peptide Therapeutic Vaccine 1.2.4 Cell Therapeutic Vaccine 1.2.5 Nucleic Acid Therapeutic Vaccine 1.3 EMEA Therapeutic Vaccines Market by Application/End Users 1.3.1 EMEA Therapeutic Vaccines Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Oncotherapy 1.3.3 Hepatitis B 1.3.4 Tuberculosis 1.3.5 Herpes Simplex Virus 1.3.6 Others 1.4 EMEA Therapeutic Vaccines Market by Region 1.4.1 EMEA Therapeutic Vaccines Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of Therapeutic Vaccines (2013-2025) 1.5.1 EMEA Therapeutic Vaccines Sales and Growth Rate (2013-2025) 1.5.2 EMEA Therapeutic Vaccines Revenue and Growth Rate (2013-2025) 2 EMEA Therapeutic Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Therapeutic Vaccines Market Competition by Players/Manufacturers 2.1.1 EMEA Therapeutic Vaccines Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA Therapeutic Vaccines Revenue and Share by Players (2013-2018) 2.1.3 EMEA Therapeutic Vaccines Sale Price by Players (2013-2018) 2.2 EMEA Therapeutic Vaccines (Volume and Value) by Type/Product Category 2.2.1 EMEA Therapeutic Vaccines Sales and Market Share by Type (2013-2018) 2.2.2 EMEA Therapeutic Vaccines Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA Therapeutic Vaccines Sale Price by Type (2013-2018) 2.3 EMEA Therapeutic Vaccines (Volume) by Application 2.4 EMEA Therapeutic Vaccines (Volume and Value) by Region 2.4.1 EMEA Therapeutic Vaccines Sales and Market Share by Region (2013-2018) 2.4.2 EMEA Therapeutic Vaccines Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA Therapeutic Vaccines Sales Price by Region (2013-2018) 3 Europe Therapeutic Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Therapeutic Vaccines Sales and Value (2013-2018) 3.1.1 Europe Therapeutic Vaccines Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe Therapeutic Vaccines Revenue and Growth Rate (2013-2018) 3.2 Europe Therapeutic Vaccines Sales and Market Share by Type 3.3 Europe Therapeutic Vaccines Sales and Market Share by Application 3.4 Europe Therapeutic Vaccines Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Therapeutic Vaccines Sales Volume by Countries (2013-2018) 3.4.2 Europe Therapeutic Vaccines Revenue by Countries (2013-2018) 3.4.3 Germany Therapeutic Vaccines Sales and Growth Rate (2013-2018) 3.4.4 France Therapeutic Vaccines Sales and Growth Rate (2013-2018) 3.4.5 UK Therapeutic Vaccines Sales and Growth Rate (2013-2018) 3.4.6 Russia Therapeutic Vaccines Sales and Growth Rate (2013-2018) 3.4.7 Italy Therapeutic Vaccines Sales and Growth Rate (2013-2018) 3.4.8 Benelux Therapeutic Vaccines Sales and Growth Rate (2013-2018) 4 Middle East Therapeutic Vaccines (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Therapeutic Vaccines Sales and Value (2013-2018) 4.1.1 Middle East Therapeutic Vaccines Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East Therapeutic Vaccines Revenue and Growth Rate (2013-2018) 4.2 Middle East Therapeutic Vaccines Sales and Market Share by Type 4.3 Middle East Therapeutic Vaccines Sales and Market Share by Application 4.4 Middle East Therapeutic Vaccines Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Therapeutic Vaccines Sales Volume by Countries (2013-2018) 4.4.2 Middle East Therapeutic Vaccines Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia Therapeutic Vaccines Sales and Growth Rate (2013-2018) 4.4.4 Israel Therapeutic Vaccines Sales and Growth Rate (2013-2018) 4.4.5 UAE Therapeutic Vaccines Sales and Growth Rate (2013-2018) 4.4.6 Iran Therapeutic Vaccines Sales and Growth Rate (2013-2018) 5 Africa Therapeutic Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Therapeutic Vaccines Sales and Value (2013-2018) 5.1.1 Africa Therapeutic Vaccines Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa Therapeutic Vaccines Revenue and Growth Rate (2013-2018) 5.2 Africa Therapeutic Vaccines Sales and Market Share by Type 5.3 Africa Therapeutic Vaccines Sales and Market Share by Application 5.4 Africa Therapeutic Vaccines Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Therapeutic Vaccines Sales Volume by Countries (2013-2018) 5.4.2 Africa Therapeutic Vaccines Revenue by Countries (2013-2018) 5.4.3 South Africa Therapeutic Vaccines Sales and Growth Rate (2013-2018) 5.4.4 Nigeria Therapeutic Vaccines Sales and Growth Rate (2013-2018) 5.4.5 Egypt Therapeutic Vaccines Sales and Growth Rate (2013-2018) 5.4.6 Algeria Therapeutic Vaccines Sales and Growth Rate (2013-2018) 6 EMEA Therapeutic Vaccines Manufacturers/Players Profiles and Sales Data 6.1 Northeast Biotherapeutics 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Therapeutic Vaccines Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Agenus 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Therapeutic Vaccines Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Vaccinogen Inc 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Therapeutic Vaccines Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 CIMAB S.A 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Therapeutic Vaccines Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Dendreon 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Therapeutic Vaccines Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Corixa 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Therapeutic Vaccines Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 AVAX 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Therapeutic Vaccines Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 AVAX Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview ... 7 Therapeutic Vaccines Manufacturing Cost Analysis 7.1 Therapeutic Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Therapeutic Vaccines 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Therapeutic Vaccines Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Therapeutic Vaccines Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Therapeutic Vaccines Market Forecast (2018-2025) 11.1 EMEA Therapeutic Vaccines Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA Therapeutic Vaccines Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA Therapeutic Vaccines Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA Therapeutic Vaccines Price and Trend Forecast (2018-2025) 11.2 EMEA Therapeutic Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe Therapeutic Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt Therapeutic Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa Therapeutic Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA Therapeutic Vaccines Sales Forecast by Type (2018-2025) 11.7 EMEA Therapeutic Vaccines Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Therapeutic Vaccines Figure EMEA Therapeutic Vaccines Sales Volume (K Pcs) by Type (2013-2025) Figure EMEA Therapeutic Vaccines Sales Volume Market Share by Type (Product Category) in 2017 Figure Peptide Therapeutic Vaccine Product Picture Figure Cell Therapeutic Vaccine Product Picture Figure Nucleic Acid Therapeutic Vaccine Product Picture Figure EMEA Therapeutic Vaccines Sales Volume (K Pcs) by Application (2013-2025) Figure EMEA Sales Market Share of Therapeutic Vaccines by Application in 2017 Figure Oncotherapy Examples Table Key Downstream Customer in Oncotherapy Figure Hepatitis B Examples Table Key Downstream Customer in Hepatitis B Figure Tuberculosis Examples Table Key Downstream Customer in Tuberculosis Figure Herpes Simplex Virus Examples Table Key Downstream Customer in Herpes Simplex Virus Figure Others Examples Table Key Downstream Customer in Others Figure EMEA Therapeutic Vaccines Market Size (Million USD) by Region (2013-2025) Figure Europe Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Therapeutic Vaccines Revenue (Million USD) Status and Forecast by Countries Figure Middle East Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East Therapeutic Vaccines Revenue (Million USD) Status and Forecast by Countries Figure Africa Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa Therapeutic Vaccines Revenue (Million USD) Status and Forecast by Countries Figure EMEA Therapeutic Vaccines Sales Volume and Growth Rate (2013-2025) Figure EMEA Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA Therapeutic Vaccines Market Major Players Product Sales Volume (K Pcs) (2013-2018) Table EMEA Therapeutic Vaccines Sales Volume (K Pcs) of Major Players (2013-2018) Table EMEA Therapeutic Vaccines Sales Share by Players (2013-2018) Figure 2017 Therapeutic Vaccines Sales Share by Players Figure 2017 Therapeutic Vaccines Sales Share by Players Figure EMEA Therapeutic Vaccines Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA Therapeutic Vaccines Revenue (Million USD) by Players (2013-2018) Table EMEA Therapeutic Vaccines Revenue Share by Players (2013-2018) Table 2017 EMEA Therapeutic Vaccines Revenue Share by Players Table 2017 EMEA Therapeutic Vaccines Revenue Share by Players Table EMEA Therapeutic Vaccines Sale Price (USD/Pcs) by Players (2013-2018) Table EMEA Therapeutic Vaccines Sales (K Pcs) and Market Share by Type (2013-2018) Table EMEA Therapeutic Vaccines Sales Share by Type (2013-2018) Figure Sales Market Share of Therapeutic Vaccines by Type (2013-2018) Figure EMEA Therapeutic Vaccines Sales Market Share by Type (2013-2018) Table EMEA Therapeutic Vaccines Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA Therapeutic Vaccines Revenue Share by Type (2013-2018) Figure Revenue Market Share of Therapeutic Vaccines by Type in 2017 Table EMEA Therapeutic Vaccines Sale Price (USD/Pcs) by Type (2013-2018) Table EMEA Therapeutic Vaccines Sales (K Pcs) and Market Share by Application (2013-2018) Table EMEA Therapeutic Vaccines Sales Share by Application (2013-2018) Figure Sales Market Share of Therapeutic Vaccines by Application (2013-2018) Figure EMEA Therapeutic Vaccines Sales Market Share by Application in 2017 Table EMEA Therapeutic Vaccines Sales (K Pcs) and Market Share by Region (2013-2018) Table EMEA Therapeutic Vaccines Sales Share by Region (2013-2018) Figure Sales Market Share of Therapeutic Vaccines by Region (2013-2018) Figure EMEA Therapeutic Vaccines Sales Market Share in 2017 Table EMEA Therapeutic Vaccines Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA Therapeutic Vaccines Revenue Share by Region (2013-2018) Figure Revenue Market Share of Therapeutic Vaccines by Region (2013-2018) Figure EMEA Therapeutic Vaccines Revenue Market Share Regions in 2017 Table EMEA Therapeutic Vaccines Sales Price (USD/Pcs) by Region (2013-2018) Figure Europe Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Europe Therapeutic Vaccines Revenue and Growth Rate (2013-2018) Table Europe Therapeutic Vaccines Sales (K Pcs) by Type (2013-2018) Table Europe Therapeutic Vaccines Market Share by Type (2013-2018) Figure Europe Therapeutic Vaccines Market Share by Type in 2017 Table Europe Therapeutic Vaccines Sales (K Pcs) by Application (2013-2018) Table Europe Therapeutic Vaccines Market Share by Application (2013-2018) Figure Europe Therapeutic Vaccines Market Share by Application in 2017 Table Europe Therapeutic Vaccines Sales (K Pcs) by Countries (2013-2018) Table Europe Therapeutic Vaccines Sales Market Share by Countries (2013-2018) Figure Europe Therapeutic Vaccines Sales Market Share by Countries (2013-2018) Figure Europe Therapeutic Vaccines Sales Market Share by Countries in 2017 Table Europe Therapeutic Vaccines Revenue (Million USD) by Countries (2013-2018) Table Europe Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Europe Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Europe Therapeutic Vaccines Revenue Market Share by Countries in 2017 Figure Germany Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure France Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure UK Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Russia Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Italy Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Benelux Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Middle East Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Middle East Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East Therapeutic Vaccines Sales (K Pcs) by Type (2013-2018) Table Middle East Therapeutic Vaccines Market Share by Type (2013-2018) Figure Middle East Therapeutic Vaccines Market Share by Type (2013-2018) Table Middle East Therapeutic Vaccines Sales (K Pcs) by Applications (2013-2018) Table Middle East Therapeutic Vaccines Market Share by Applications (2013-2018) Figure Middle East Therapeutic Vaccines Sales Market Share by Application in 2017 Table Middle East Therapeutic Vaccines Sales Volume (K Pcs) by Countries (2013-2018) Table Middle East Therapeutic Vaccines Sales Volume Market Share by Countries (2013-2018) Figure Middle East Therapeutic Vaccines Sales Volume Market Share by Countries in 2017 Table Middle East Therapeutic Vaccines Revenue (Million USD) by Countries (2013-2018) Table Middle East Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Middle East Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Middle East Therapeutic Vaccines Revenue Market Share by Countries in 2017 Figure Saudi Arabia Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Israel Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure UAE Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Iran Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Africa Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Africa Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2013-2018) Table Africa Therapeutic Vaccines Sales (K Pcs) by Type (2013-2018) Table Africa Therapeutic Vaccines Sales Market Share by Type (2013-2018) Figure Africa Therapeutic Vaccines Sales Market Share by Type (2013-2018) Figure Africa Therapeutic Vaccines Sales Market Share by Type in 2017 Table Africa Therapeutic Vaccines Sales (K Pcs) by Application (2013-2018) Table Africa Therapeutic Vaccines Sales Market Share by Application (2013-2018) Figure Africa Therapeutic Vaccines Sales Market Share by Application (2013-2018) Table Africa Therapeutic Vaccines Sales Volume (K Pcs) by Countries (2013-2018) Table Africa Therapeutic Vaccines Sales Market Share by Countries (2013-2018) Figure Africa Therapeutic Vaccines Sales Market Share by Countries (2013-2018) Figure Africa Therapeutic Vaccines Sales Market Share by Countries in 2017 Table Africa Therapeutic Vaccines Revenue (Million USD) by Countries (2013-2018) Table Africa Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Africa Therapeutic Vaccines Revenue Market Share by Countries (2013-2018) Figure Africa Therapeutic Vaccines Revenue Market Share by Countries in 2017 Figure South Africa Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Nigeria Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Egypt Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Algeria Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Table Northeast Biotherapeutics Therapeutic Vaccines Basic Information List Table Northeast Biotherapeutics Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Northeast Biotherapeutics Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Northeast Biotherapeutics Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure Northeast Biotherapeutics Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table Agenus Therapeutic Vaccines Basic Information List Table Agenus Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Agenus Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Agenus Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure Agenus Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table Vaccinogen Inc Therapeutic Vaccines Basic Information List Table Vaccinogen Inc Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Vaccinogen Inc Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Vaccinogen Inc Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure Vaccinogen Inc Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table CIMAB S.A Therapeutic Vaccines Basic Information List Table CIMAB S.A Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure CIMAB S.A Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure CIMAB S.A Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure CIMAB S.A Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table Dendreon Therapeutic Vaccines Basic Information List Table Dendreon Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Dendreon Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Dendreon Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure Dendreon Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table Corixa Therapeutic Vaccines Basic Information List Table Corixa Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Corixa Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure Corixa Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure Corixa Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table AVAX Therapeutic Vaccines Basic Information List Table AVAX Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AVAX Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2013-2018) Figure AVAX Therapeutic Vaccines Sales Market Share in EMEA (2013-2018) Figure AVAX Therapeutic Vaccines Revenue Market Share in EMEA (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Therapeutic Vaccines Figure Manufacturing Process Analysis of Therapeutic Vaccines Figure Therapeutic Vaccines Industrial Chain Analysis Table Raw Materials Sources of Therapeutic Vaccines Major Manufacturers in 2017 Table Major Buyers of Therapeutic Vaccines Table Distributors/Traders List Figure EMEA Therapeutic Vaccines Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure EMEA Therapeutic Vaccines Revenue and Growth Rate Forecast (2018-2025) Figure EMEA Therapeutic Vaccines Price (USD/Pcs) and Trend Forecast (2018-2025) Table EMEA Therapeutic Vaccines Sales (K Pcs) Forecast by Region (2018-2025) Figure EMEA Therapeutic Vaccines Sales Market Share Forecast by Region (2018-2025) Table EMEA Therapeutic Vaccines Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA Therapeutic Vaccines Revenue Market Share Forecast by Region (2018-2025) Table Europe Therapeutic Vaccines Sales (K Pcs) Forecast by Countries (2018-2025) Figure Europe Therapeutic Vaccines Sales Market Share Forecast by Countries (2018-2025) Table Europe Therapeutic Vaccines Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe Therapeutic Vaccines Revenue Market Share Forecast by Countries (2018-2025) Table Middle East Therapeutic Vaccines Sales (K Pcs) Forecast by Countries (2018-2025) Figure Middle East Therapeutic Vaccines Sales Market Share Forecast by Countries (2018-2025) Table Middle East Therapeutic Vaccines Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East Therapeutic Vaccines Revenue Market Share Forecast by Countries (2018-2025) Table Africa Therapeutic Vaccines Sales (K Pcs) Forecast by Countries (2018-2025) Figure Africa Therapeutic Vaccines Sales Market Share Forecast by Countries (2018-2025) Table Africa Therapeutic Vaccines Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa Therapeutic Vaccines Revenue Market Share Forecast by Countries (2018-2025) Table EMEA Therapeutic Vaccines Sales (K Pcs) Forecast by Type (2018-2025) Figure EMEA Therapeutic Vaccines Sales Market Share Forecast by Type (2018-2025) Table EMEA Therapeutic Vaccines Sales (K Pcs) Forecast by Application (2018-2025) Figure EMEA Therapeutic Vaccines Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources